Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07051707 · ClinicalTrials.gov registry record · NA
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
A NA study of Chronic Obstructive Pulmonary Disease and COPD, sponsored by Nuvaira.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 6
- Study locations
NCT07051707 is a NA study of Chronic Obstructive Pulmonary Disease and COPD that is actively recruiting participants, run by Nuvaira. The registered enrollment target is 200 participants, below the 1,752-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT07051707, a NA study of Chronic Obstructive Pulmonary Disease and COPD, is actively recruiting participants, sponsored by Nuvaira.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard medical care. The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System in the treatment of COPD.
Conditions Studied
Interventions
- DEVICE Targeted Lung Denervation (TLD)
Study Locations (6)
Pennsylvania
- Penn Highlands - Lung Innovations/Clinical Research Associates - DuBois
- Temple University - Temple Lung Center - Philadelphia
- University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center - Pittsburgh
Alabama
- University of Alabama-Birmingham Hospital - UAB Lung Health Center - Birmingham
Michigan
- Henry Ford Hospital - Lung and Pulmonary Care - Detroit
Ohio
- Ohio State University Medical Center - Ohio State Lung Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-02-15 |
| Est. Completion | 2029-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07051707
The ClinicalTrials.gov registry entry for NCT07051707 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,752-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (89% lower). The listed sponsor is Nuvaira, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Targeted Lung Denervation (TLD) is the first listed.
NCT07051707 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Pennsylvania, Alabama, Michigan.
Frequently Asked Questions
What is clinical trial NCT07051707 about?
NCT07051707 is a clinical study titled "Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD". The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard medical care. The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System in the treatment of COPD.
What is the current status of trial NCT07051707?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-02-15. Estimated completion is 2029-10-31.
What conditions does trial NCT07051707 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease, COPD.
What interventions are being tested in trial NCT07051707?
The interventions under investigation include: Targeted Lung Denervation (TLD) (DEVICE).
Who is sponsoring clinical trial NCT07051707?
This trial is sponsored by Nuvaira, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07051707 being conducted?
This trial has 6 study locations across Alabama, Michigan, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
RECRUITING · NA
-
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
RECRUITING · NA
-
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
RECRUITING · NA
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.